Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies
In the last decade, immune therapies against human cancers have emerged as a very effective therapeutic strategy in the treatment of various cancers, some of which are resistant to current therapies. Although the clinical responses achieved with many therapeutic strategies were significant in a subs...
Main Authors: | Emily Hays, Benjamin Bonavida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/8/9/407 |
Similar Items
-
Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies
by: Malina Xiao, et al.
Published: (2021-02-01) -
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
by: Joel Mintz, et al.
Published: (2021-01-01) -
Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
by: Maria Kowalska, et al.
Published: (2016-05-01) -
Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy
by: Christina Janko, et al.
Published: (2019-02-01) -
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
by: Concetta Panebianco, et al.
Published: (2018-05-01)